Difference between revisions of "Team:Harvard BioDesign"
Line 103: | Line 103: | ||
<h2 class="alt">Welcome to the <strong>Harvard BioDesign 2015</strong> wiki!</h2><br/> | <h2 class="alt">Welcome to the <strong>Harvard BioDesign 2015</strong> wiki!</h2><br/> | ||
<p>The "official" place where flocculation happens and llamas are appreciated.</p> | <p>The "official" place where flocculation happens and llamas are appreciated.</p> | ||
− | <img src="https://static.igem.org/mediawiki/2015/3/38/HarvardLlamaoutline.png" alt="Email Logo" style="width: | + | <img src="https://static.igem.org/mediawiki/2015/3/38/HarvardLlamaoutline.png" alt="Email Logo" style="width:127px;height:150px;"> |
</header> | </header> | ||
Revision as of 16:21, 15 July 2015
![Harvard Logo](https://static.igem.org/mediawiki/2015/9/94/HarvardBioDesign2015Logo2.png)
NAME OF PROJECT
Welcome to the Harvard BioDesign 2015 wiki!
The "official" place where flocculation happens and llamas are appreciated.
![Email Logo](https://static.igem.org/mediawiki/2015/3/38/HarvardLlamaoutline.png)
About Our Project
Our team is engineering E. coli to bind to colon cancer cells through the use of their type I pili, which are hair-like appendages
that have an adhesive domain. Naturally, the strains in E. coli that produce pili bind to alpha-D-mannose, which can cause urinary track infections.
However, our team is altering a non-harmful strain to produce pili using a modified Fim gene in order to localize the bacteria as a tool. For treatment of cancer,
once the bacteria are localized on the cells, the next step is to make the